chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter. No treatment medication was provided.  Patient received dose from vial refrigerated on 19-AUG-2021.   This case was linked to MOD-2021-364760 (Patient Link).
Left arm shooting pain, can not lift my arm and having trouble with daily activities because am not able to use my arm, the symptoms have been present since the end of February
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitants and Treatment medications were reported.   This case was linked to MOD-2021-399960, MOD-2021-405538, MOD-2021-405545, MOD-2021-405575, MOD-2021-405585, MOD-2021-405622, MOD-2021-405652, MOD-2021-405659, MOD-2021-405696, MOD-2021-405721 (Patient Link).
During today's vaccine clinic, pt very upset and frustrated that she received the Pfizer vaccine instead of Moderna vaccine.  Patient states she was on the phone with scheduling for 45 minutes to 1 hour yesterday discussing her need to get Moderna.    She  has a history of anaphylaxis to several antibiotics that resulted in a code and ICU level stay.  She states she spoke with her physician and family as well as researched to determine that Moderna or Johnson & Johnson was the safest for her to receive with her history of severe reactions.  She came to our clinic (traveled some distance) per the information from scheduling that at this clinic is giving Moderna.    Patient went through the process and didn't realize until after vaccine was administered that she received the Pfizer vaccine instead of Moderna.  Patient is very concerned of what may happen since she received the Pfizer.  Today is the second day (yesterday was the first) of company doing Pfizer.  After discussion the following items were discussed for follow up:  1) Registration staff and administering RNs (prior to administration) will let patients know which they are getting  2) A sign was created and placed where registration is that states the vaccine being given that day (per husband's suggestion)  3) Notified vaccine clinic leadership and scheduling leadership  4) Have patient relations follow up with her early next week  5) Monitored patient for 30 minutes and explained side effects and need to contact PCP or go to ER with symptoms pertaining to anaphylaxis reaction  no reaction reported
1) Fatigue: I slept more than 11 hours the night of getting my shot. I usually sleep 7 hours (1 day) 2) Extreme upper arm  pain,  visibly swollen with a  "hard" feeling knot of muscle underneath (2 days) 3) Arm that was extremely hot to the touch and very itchy (2 days) 4) "Foggy" brain, unable to  clearly focus (1 day)
4/24/17 Fever and rash. 5/1/17 Rash changed. 5/12/17 Rash resolved.
Patient admitted after being administered second dose in Pfizer series that he had already received the J&J vaccination at an earlier date. Upon further inspect, verified this with ALERT system for vaccination tracking.
Feeling tired on the second day (27Feb2021) after vaccination of the 2nd dose.; A little bit muscle aches around the injection site and on the back; This is a spontaneous report from a contactable consumer or other non hcp. A 35-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in Arm Left on 26Feb2021 14:30 (at the age of 35-years-old) as dose 2, single for covid-19 immunisation. The medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. The patient did not receive any other medication within 2 weeks of vaccination. The patient did not received treatment for the adverse event. The patient received first dose of BNT162B2 on 05Feb2021 at 2:15 PM (lot number: EL3247, Location: left arm) for covid-19 immunization. On 27Feb2021 at 10:00 the patient experienced feeling tired on the second day (27feb2021) after vaccination of the 2nd dose and a little bit muscle aches around the injection site and on the back. The outcome of both the events was resolving. No follow-up attempts are needed. No further information is expected.
In database the patient received the second dose on Pfizer Covid 19 vaccine on 4/27/21. In database the date was manually changed to reflect to dose given on 4/30/21. At that time there was no grace period for early vaccinations. The vaccinator on 4/27/21 in database was, RN. When the date was manually changed to 4/30/21 in database the vaccinator was changed to, RN.
dehydration; Headache; nausea; vomiting; This is a spontaneous report from a contactable physician. A 25-year-old female patient (no pregnancy) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, lot number: EL0142), intramuscularly at site of right arm on 28Dec2020 at single dose for COVID-19 immunization. Age at vaccination was 25-year-old. Medical history included COVID-19 (Prior to vaccination, the patient was diagnosed with COVID-19). The patient's concomitant medications were not reported. The patient experienced headache, nausea, vomiting, dehydration on 29Dec2020. Events were resulted in emergency room/department or urgent care. The patient received treatment (IV fluids, ondansetron (ZOFRAN), metoclopramide (REGLAN)) for the adverse event. Facility where the most recent COVID-19 vaccine was administered in hospital. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was recovering.
14 days after vaccine I started severe diarrhea; severe joint aches; Coughing; 4 Days after I had a strange headache for 2 days; then felt fatigue; fever of 99 for an afternoon; noticed lungs seemed different as breathless, which progressed to a little pressure which I have never had before; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 76-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: EN6203) via an unspecified route of administration (age at vaccination 76-year) in right arm on 28Feb2021 at 01:15 PM as dose 1, single for COVID-19 immunization. Medical history included diverticulitis; SOD; emphysema; Known allergies: several drugs, bee/wasp stings, msg, most preservatives; all from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium (SYNTHROID); tiotropium bromide (SPIRIVA RESPIMAT); vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]); vitamin d nos (VITAMIN D NOS); all taken in two weeks of COVID vaccination, for an unspecified indication, start and stop date were not reported. The patient received no COVID prior vaccination. The patient not tested COVID post vaccination. Patient received no other vaccine in four weeks. Reported facility type vaccine was Doctor's office/urgent care. The patient experienced 4 days after she had a strange headache on 04Mar2021 for 2 days; then felt fatigue, fever of 99 for an afternoon, noticed lungs seemed different as breathless, which progressed to a little pressure which she never had before, on an unspecified date in Mar2021; 14 days after vaccine she started severe diarrhea, severe joint aches, coughing, on 14Mar2021. It was reported that "She never had before though, she had emphysema. Called her physician and she said to not take scheduled second shot when scheduled on 14Mar2021. Then she was concerned of what's next." AE resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures on an unspecified date which included body temperature: 99 (fever of 99). The patient received no treatment for the adverse events. The clinical outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Itchy rash on jaw line morning of 10/31/22. Took benadryl for itchiness. Injection site reaction red, raised, 2 in circle, warm to the touch.
No adverse event per se. had sore throat and funny nose. Rapid antigen test was positive so had to notify medical staff on cruise ship.  They confirmed positivity via PCR test and immediately initiated my isolation for 6 days with release after negative test
Initial report received from a healthcare professional on 28 JANUARY 2013. A 70-year-old female patient, had received first dose of FLUZONE (lot number: not available, route, and site of administration were not reported), on16 JANUARY 2013. The patient had no pre-existing physician diagnosed allergies, birth defects, medical conditions and illness at time of vaccination. The patient's concomitant medications were not reported. On 23 JANUARY 2013, i.e. one week after vaccination, the patient developed racing heartbeat. Laboratory data and corrective treatment details were not reported. The patient had not recovered from the event at the time of this report. Follow up information received from a healthcare professional on 01 JULY 2013. The patient experienced gastroenteritis, diarrhea and vomiting on an unspecified date and it was reported that patient was sure symptoms were unrelated to vaccine. The patient had not received any vaccine within 4 weeks of 16 JANUARY 2013. On an unspecified date, the patient had recovered from the events.  Documents held by sender: none
Received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a patient who received DTPa-HBV-IPV (DTPa-HBV-IPV) (batch number BZ24H) for prophylaxis.   On 26-JAN-2023, the patient received DTPa-HBV-IPV. On an unknown date, an unknown time after receiving DTPa-HBV-IPV, the patient experienced incorrect storage of drug (Verbatim: Received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The patient age is reported that less than a one year The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
23SEP91 red tender @ inject site (swelling); 24SEP91 ER visit (red & sore); 25SEP91 excised & drained abscess; 27SEP91 temp spiked;
3PM pt c/o itching;no hives or other sx;DPH taken by pt 3:45PM;no sx;itching disappeared;pt reported on 23OCT that on 22OCT 530PM had chills & fever (fever# unk);23OCT T102 c/o achiness;24OCT97 all sx disappeared;
On Monday Sep 18 the patient began to feel tired. On Tuesday Sep 19 the patient began to sweat and had to lie down on the bed because she felt she was going to faint (similar to vasovagal syndrome), also had nausea. On Wednesday Sep 20 the patient had nausea. On Thursday Sep 21 the patient began to have vertigo in addition to nausea. On Friday Sep 21 the patient felt tired, nauseous, and with vertigo, so that day in the afternoon, I decided to take her to Dr., our primary care physician.
High temp, dizzy, headache, sleepy, exhausted, lethargic, chills
Pt had reaction to DTP and IPV - left arm - redness cellulitis. Came to see Dr. on 7/26/07 - was treated with Augmentin 400 x5 day also to take Benadryl.
Unknown what if any adverse event may have occurred.   This report is being submitted following a periodic review of death certificates .    Death certificate for this individual indicates "recent COVID vaccine" in   "PART II. OTHER SIGNIFICANT CONDITIONS contributing to death but not resulting in the underlying cause"
Infanrix was administered to a patient came in who is 7; Product label confusion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old patient who received DTPa (Infanrix) (batch number 7HM5J, expiry date 13-SEP-2024) for prophylaxis. This case was associated with a product complaint.   On 09-AUG-2023, the patient received Infanrix. On 09-AUG-2023, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Infanrix was administered to a patient came in who is 7) and product label confusion (Verbatim: Product label confusion). The outcome of the inappropriate age at vaccine administration and product label confusion were unknown.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: Receipt date: 10-AUG-2023 The reporter reported that the Infanrix was administered to patient came in who was 7 and they wanted to know the way to proceed. The reporter stated that there was some confusion with the Infanrix as it stated on the box that it could be administered to patients who were 6-7 years of age but the package insert said administer prior to the 7th birthday. Health care professional (HCP) did not have the patient's demographics at time of call.  The vaccine administration facility was the same as primary reporter. The 7 year old patient received Infanrix, which led to inappropriate age at vaccine administration. The reporter had confusion on the box label, which led product label confusion. The reporter consented to follow up via post.
Mother noted red area about the size of nickle on right thigh when she removed band aid from injection site at about 8pm on day of vaccination. At apprx. 9am the folowing day are was swollen with large area of induration. No fever, pain or fussiness reported. PMD was notified. Tylenol prescribed. 10/24/2002- spoke to mother  redness and swelling are resolving.
The following day had arm pain and fatigue for three and a half days, nasal congestion, dry eyes and itchy throat. Got tested for COVID one week later and is positive.
Sore injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore injection site arm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore injection site arm). At the time of the report, VACCINATION SITE PAIN (Sore injection site arm) outcome was unknown.            No concurrent and treatment medication was reported by patient.   This case was linked to MOD-2021-297362, MOD-2021-297494 (Patient Link).
After 2d vaccine. Fever 101,fatigue, body aches, stomach cramping and pain, headache then diarrhea/ gas  for 2 days Then 3 weeks later Fever 100.4. Stomach pains and diarrhea and gas for 24 hours. Then 2 1/2 weeks later Fever 100.3  stomach pains, diarrhea and gas for 24 hours
Pt devel an erythematous rxn in rt deltoid following admnistration of Td; area of rxn was 3 cm x 3 cm;
Parents observed jerky movements and child was taken to the ER. This was the day after vaccination. Also had a fever, low grade.
Nosebleeds began weekly for 3 weeks approximately 1 week after dose 1 on 2/9/21 but I was able to stop them.  However the 4th nosebleed on 3/17 could not be stopped and I was forced to call 911 and I was taken be ambulance to the emergency room.
13 days after my first dose I broke out in a blistering rash on my arms and legs with severe swelling. My dermatologist diagnosed me with Pemphigoid Gestationis via a biopsy- despite it being rare and usually occurring in 2nd/3rd trimester, while I was 3 weeks postpartum. Could it be related to getting the vaccine postpartum while on a low dosage of prednisone?  I?d been told by my endocrinologist it was tempered enough for me to get the vaccine. I was also told by my neurologist and endocrinologist the PG rash was unrelated to the bleed on my pituitary gland. I didn?t have PG with my other two pregnancies. The only new factor was my increased age and the vaccine.
Skin Infection after falling; Fell down and hurt herself; Sore left arm; Could not lift arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm), HYPOKINESIA (Could not lift arm), SKIN INFECTION (Skin Infection after falling) and FALL (Fell down and hurt herself) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm) and HYPOKINESIA (Could not lift arm). On 16-Apr-2021, the patient experienced SKIN INFECTION (Skin Infection after falling) and FALL (Fell down and hurt herself). On 04-Apr-2021, PAIN IN EXTREMITY (Sore left arm) and HYPOKINESIA (Could not lift arm) had resolved. On 16-May-2021, FALL (Fell down and hurt herself) had resolved. At the time of the report, SKIN INFECTION (Skin Infection after falling) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing was delayed on an unknown date.       Patient was prescribed antibiotics for skin infection.  No concomitant medications were reported.
pt recvd vax 8AUG94 & 2 days later exp achy joints & flu-like sx; this occurence of these sx was milder than dose 1;
Asthma start going about 20 minutes after shot ,   hour later my stomach bothered me and dizzy off balance and my whole arm hurt. I tried taking  2  ibuprofen and then 2  tylenol switching every 3 hours and it didn't  help with the first two days. than  it started help the third day . the symptoms last a good four days brfore they started getting better.
Received the vaccine and had no problems, felt fatigued over the weekend.  On Monday 3/8/21, the upper arm/elbow area she occasionally experiences a deep pain.  She does have nerve damage in that arm from an injury as a child and feels that the vaccine has triggered this response.  It comes and goes, does not last long.  She is still having that intermittent feeling.  She has taken Tylenol for the symptoms.
sick; This case was reported by a consumer and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as the case reported by patient. The age at vaccination was not reported. The patient stated that she/he just had shingles shot and sadly it made patient sick..
Increased weakness, unable to stand with walker last few days, increase fatigue and diarrhea today was found to be COVID positive  vaccine #3 9/1/2021
Muscle soar and nerve pinch  starting at right shoulder to rib cage; Could  not lift right arm, pinch nerve pain from right upper body to hair of the lower head area;  Could not lye on bed
Extreme dizziness; flu like symptoms; trouble breathing; rash on right side of body; This is a spontaneous report from a contactable consumer. This 29-year-old non-pregnant female consumer (patient) reported that she received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number, batch number; unknown as obscured by other product labelling, NDC number, UPC number, expiry date; unknown) via an unspecified route of administration on 17Mar2021 at 13: 00 (1:00 pm) (age at vaccination 29-year-old) at right arm as dose 2, single for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Past vaccine included first dose of BNT162B2, lot number; unknown on an unspecified date for covid-19 immunisation. Past drug event included known allergies to Sulfa drugs. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient's concomitant medication included Sertraline, Omeprazole for unknown indication. It was reported that, Patient experienced extreme dizziness and trouble breathing, flu like symptoms and rash on right side of body on 18Mar2021 at 12:00 am. AE resulted in none of the above. When probed for the concern, Reported that patiient received her second dose of Pfizer vaccine (unspecified vaccine) yesterday (17Mar2021) and she knew that flu like symptoms were common but she developed rash on the right part of her body. she received my dose in her right arm and she didn't know are these symptoms or not, she wanted want to know that right part of her body rash or was something concerning or it's common. When probed for event start date, consumer stated she got the shot at 1 o' Clock yesterday afternoon and I woke up at 12 am this morning with symptoms (18Mar2021). When probed for the vaccination facility name, consumer stated, no, Idea it was at clinic. As consumer abruptly hung up the call. Product details (LOT#, expiration date, NDC# and UPC#), Pharmacy details and further probing could not be done. Hence, limited information was available over the call and appropriate response could not be provided. It was unknown if the treatment was received for the adverse event. The patient has not been tested for COVID-19. The outcome of events was not recovered. Reporter seriousness for the events was unspecified.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.